CARDIOVASCULAR
The Endurity MRI™ pacemaker offers premium features and outstanding longevity in a physician-preferred physiologic shape1 and a 10 cc size. We designed this MR Conditional device to allow full-body 1.5T or 3.0T MRI scans.*
Designed for ease of implant, this 10 cc physician-preferred shape1 and size pacemaker can enable a smaller incision and pocket size.
The Endurity MRI pacemaker is MR Conditional, allowing full-body MRI scans with more efficient workflow than conventional MRI pacemakers.
Consider what improvements you can make for your patients with increased therapy assurance.
The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.
Product Manuals (Instructions for Use)
* See MRI Scan Parameters – Lead Models in MRI Scan Parameters
1. St. Jude Medical. Data on file, Report 60048640. Market Research Report: Pacemaker Size and Shape. 2012.
2. A,V = 2,5 V @ 0,4 ms; 500 ohms; 100% DDD pacing @ 60 bpm; AutoCapture™ pacing system OFF; SEGMs ON.
3. Terms and conditions apply; refer to the warranty for details.
4. Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., … Hohnloser, S. H. (2012). Subclinical atrial fibrillation and the risk of stroke. New England Journal of Medicine, 366, 120-129. http://dx.doi.org/10.1056/NEJMoa1105575
5. Faulknier, B., & Richards, M. (2012, December). The association of the use of the ventricular intrinsic preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Presented at the XV International Symposium on Progress in Clinical Pacing, Rome, Italy.
The Endurity MRI™ pacemaker’s physician-preferred size1 and physiologic shape help you minimize pocket size.1
Real-time electrogram (EGM) waveform, as well as the associated event markers that precede and follow a specific triggering event, can be programmed to automatically record up to 14 minutes of stored EGMs when encountering one or more programmable trigger options.
The only pacemaker with programmable AT/AF alerts specifically indicated for detecting atrial tachyarrhythmias, which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of AF.2
The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.
Product Manuals (Instructions for Use)
1. St. Jude Medical. Data on file, Report 60048640. Market Research Report: Pacemaker Size and Shape, 2012.
2. Healey, J. S., Connolly, S. J., Gold, M.R., Israel, C. W., Van Gelder, I. C., Capucci, A., … Hohnloser, S. H. (2012). Subclinical atrial fibrillation and the risk of stroke. NEW ENGLAND JOURNAL OF MEDICINE, 366, 120-129. http://dx.doi.org/10.1056/NEJMoa1105575
3. A,V = 2,5 V @ 0,4 ms; 500 ohms; 100% VVI pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON.
4. Terms and conditions apply; refer to the warranty for details.
Single-Chamber Pacemaker
Contents: MRI Ready Pacing System
Reorder Number PM1172 |
Dimensions (H x W x T, mm) 41 x 50 x 6 |
Weight (g) 19 |
Volume (cc) 9.7 (± 0.5) |
Connector IS-1 |
Dual-Chamber Pacemaker
Contents: MRI Ready Pacing System
Reorder Number PM2172 |
Dimensions (H x W x T, mm) 6 x 50 x 6 |
Weight (g) 20 |
Volume (cc) 10.4 (± 0.5) |
Connector IS-1 |
Abbott recognized the importance of MR Conditional devices, so we designed accordingly.
Patients over 65 are at greater risk for stroke, dementia and musculoskeletal disorders.1
Unnecessary right ventricular (RV) pacing can exacerbate heart conditions.
Abbott can help. We use a Ventricular Intrinsic Preference (VIP™) algorithm with dynamic AV delay, which are clinically proven to reduce unnecessary RV pacing. The VIP algorithm is shown to reduce heart-failure related hospitalization,5 and we offer RV pacing at desirable levels (10-19%).4
The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.
1. Levy, S. THE MOST COMMON ISSUES OF AGING. www.agingcare.com/Articles/common-issues-of-aging-102224.html
2. Jauch, E. C., Saver, J. L., Adams, H. P. Jr., Bruno, A., Connors, J. J., Demaerschalk, B. M., … Yonas, H. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947. http://dx.doi.org/10.1161/STR.0b013e318284056a
3. Wilkoff, B. L., Cook, J. R., Epstein, A. E., Greene, H. L., Hallstrom, A. P., Hsia, H., … Sharma, A., & DAVID Investigators. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288(24), 3115-3123. http://www.ncbi.nlm.nih.gov/pubmed/12495391
4. Olshansky, B., Day, J., Lerew, D., Brown, S., Stolen, K. Q., & INTRINSIC RV Investigators. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm, (7), 886-891. http://www.ncbi.nlm.nih.gov/pubmed/17599672
5. Faulknier, B., & Richards, M. (2012, December). The association of the use of the Ventricular Intrinsic Preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Presented at the International Symposium on Progress in Clinical Pacing, Rome, Italy.
SJM-CV WEB-0718-0018a(1)
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
